OCLN and stroke disorder: Preventing occludin phosphorylation either genetically using vascular endothelial specific expression of the stable, S490A non-phosphorylatable form of occludin, or by inhibiting PKCbeta, blocked stroke-induced permeability while decreasing stroke volume and improving functional outcome.